Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) may improve glycemic control in patients with type 2 diabetes, reducing the risk of disease complications.
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.